Effect of Glucagon-like Peptide-1 Receptor Agonists on Prognosis of Heart Failure and Cardiac Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
葡萄糖樣肽-1 受體激動劑對心力衰竭預後和心臟功能的影響:隨機對照試驗的系統性回顧和荟萃分析。
Clin Ther 2023-03-21
The Safety and Efficacy of GLP-1 Receptor Agonists in Heart Failure Patients: A Systematic Review and Meta-Analysis.
GLP-1 受體激動劑在心衰患者中的安全性和有效性:系統性回顧和荟萃分析。
Curr Probl Cardiol 2023-03-28
Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis.
基線時心臟衰竭史對 GLP-1 受體激動劑在第二型糖尿病患者心血管效應的影響:一項荟萃分析。
Cardiovasc Drugs Ther 2024-02-16
Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
GLP-1 受體激動劑在心力衰竭患者中的臨床結果:隨機對照試驗的系統性回顧和荟萃分析。
Drugs 2023-09-21
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.
心衰中的心臟代謝藥物二型鈉葡萄糖轉運蛋白抑製劑和葡萄糖樣肽-1 受體激動劑的保護效應潛在機制。
Int J Mol Sci 2024-03-15
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries.
瑞典心臟衰竭和瑞典全國糖尿病登記資料庫中胰高血糖素樣肽-1 受體激動劑的使用及其與心臟衰竭和2型糖尿病結果的關聯。
Eur Heart J Cardiovasc Pharmacother 2024-04-17
Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: Myth or truth?
糖類似肽-1 受體激動劑在心力衰竭中的心臟保護作用:神話還是真相?
World J Diabetes 2024-05-21
Glucagon-like-peptide 1 receptor agonism and attempted suicide: A Mendelian randomisation study to assess a potential causal association.
葡萄糖樣肽-1 受體激動劑與自殺企圖:一項孟德爾隨機化研究評估潛在的因果關係。
Clin Obes 2024-05-23